These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22988360)

  • 1. Low molecular weight heparin in prophylaxis of deep vein thrombosis in Asian general surgical patients: A Kashmir experience.
    Dar TI; Wani KA; Ashraf M; Malik A; Ahmad S; Gojwari TA; Iqbal A
    Indian J Crit Care Med; 2012 Apr; 16(2):71-4. PubMed ID: 22988360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
    Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home versus in-patient treatment for deep vein thrombosis.
    Othieno R; Okpo E; Forster R
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003076. PubMed ID: 29315455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin prophylaxis of deep vein thrombosis for older patients with restricted mobility: propensity analyses of data from two multicentre, cross-sectional studies.
    Labarère J; Sevestre MA; Belmin J; Legagneux A; Barrellier MT; Thiel H; Le Roux P; Pernod G; Bosson JL;
    Drugs Aging; 2009; 26(3):263-71. PubMed ID: 19358621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery.
    Nurmohamed MT; Verhaeghe R; Haas S; Iriarte JA; Vogel G; van Rij AM; Prentice CR; ten Cate JW
    Am J Surg; 1995 Jun; 169(6):567-71. PubMed ID: 7771617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis.
    Shorr AF; Jackson WL; Weiss BM; Moores LK
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):309-16. PubMed ID: 17473570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis: meta-analysis based on original patient data.
    Koch A; Ziegler S; Breitschwerdt H; Victor N
    Thromb Res; 2001 May; 102(4):295-309. PubMed ID: 11369423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of deep venous thrombosis prophylaxis in cancer patients: implications for improving quality.
    Leonardi MJ; McGory ML; Ko CY
    Ann Surg Oncol; 2007 Feb; 14(2):929-36. PubMed ID: 17103259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis of postoperative thromboembolism with low molecular weight heparins.
    Jørgensen LN; Wille-Jørgensen P; Hauch O
    Br J Surg; 1993 Jun; 80(6):689-704. PubMed ID: 7687188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
    J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the cost of preventing postoperative deep vein thrombosis with either unfractionated or low molecular weight heparin.
    Bergqvist D; Lindgren B; Mätzsch T
    Br J Surg; 1996 Nov; 83(11):1548-52. PubMed ID: 9014669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: A randomized trial of prophylaxis with low--molecular weight heparin.
    Michot M; Conen D; Holtz D; Erni D; Zumstein MD; Ruflin GB; Renner N
    Arthroscopy; 2002 Mar; 18(3):257-63. PubMed ID: 11877611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-duration chemoprophylaxis might reduce incidence of deep vein thrombosis in Asian patients undergoing total knee arthroplasty.
    Zhang S; Htet KS; Tan XY; Wang X; Wang W; Chua W
    Knee Surg Relat Res; 2020 Nov; 32(1):58. PubMed ID: 33148340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
    Venet C; Berger C; Tardy B; Viallon A; Decousus H; Bertrand JC
    Presse Med; 2000 Jan; 29(2):68-75. PubMed ID: 10682030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duplex screening as a method of quality assurance of perioperative thromboembolism prophylaxis.
    Van Den Berg E; Bathgate B; Panagakos E; Lambrechts R; Hani M; Meissner A; Schröder M
    Int Angiol; 1999 Sep; 18(3):210-9. PubMed ID: 10688420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low molecular weight heparins].
    Agnelli G; Cosmi B
    Medicina (Firenze); 1990; 10(1):9-15. PubMed ID: 2166209
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.